Generic name: EXEMESTANE 25mg
Dosage form: tablet
Medically reviewed on January 4, 2017.
The recommended dose of AROMASIN in early and advanced breast cancer is one 25 mg tablet once daily after a meal.
- adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to AROMASIN for completion of a total of five consecutive years of adjuvant hormonal therapy.
- the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Concomitant use of strong CYP 3A4 inducers decreases exemestane exposure, For patients receiving AROMASIN with a strong CYP 3A4 inducer such as rifampicin or phenytoin, the recommended dose of AROMASIN is 50 mg once daily after a meal [see Drug Interactions (7) and Clinical Pharmacology (12.3)].
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Aromasin (exemestane)
- Aromasin Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 13 Reviews
- Generic Availability
- Drug class: aromatase inhibitors